The PCMP-E79 Antibody is produced by Cusabio, a biotechnology company specializing in custom antibody development. Production involves:
Antigen Design: Likely utilizes recombinant protein antigens for immunization.
Purification: Multi-step chromatography to achieve high purity.
Quality Control: Rigorous testing for specificity and functionality .
While explicit research findings for PCMP-E79 are not publicly disclosed, antibodies with similar profiles are typically used in:
Immunoassays: ELISA, Western blot, and immunohistochemistry.
Diagnostics: Detection of specific biomarkers in clinical samples.
Basic Research: Protein interaction studies and cellular localization.
No peer-reviewed studies or preclinical/clinical data are available for PCMP-E79 .
Epitope mapping, cross-reactivity, and stability under long-term storage conditions remain uncharacterized.
Further research should focus on:
Functional Characterization: Neutralization assays or target modulation studies.
Structural Analysis: Cryo-EM or X-ray crystallography to define binding epitopes.
Clinical Utility: Validation in disease models or biomarker panels.